Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer
Impact of circadian rhythms on cellular functions points to better ways to treat cancer
Circulating tumor cells (CTCs) were more likely to move through vessel walls during sleep, and were highly prone to metastasize. Single-cell RNA sequencing revealed the genetic upregulation responsible for the metastatic potential.
March 24, 2023
U.S. IVD market reaches $53 billion
According to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.
March 22, 2023
Mailing HPV self-sampling kits for cervical cancer screening was cost-effective in study
The study, published Wednesday in JAMA Network Open, supports mailing HPV kits as an efficient outreach strategy for increasing screening rates among eligible women.
March 22, 2023
Guardant Health, Ohio State University study colorectal cancer screening adherence
The Ohio State University-led study will evaluate changes in CRC screening adherence in underserved urban and rural communities. Guardant Health is providing its Shield blood test to eligible individuals through mobile health clinic partners.
March 21, 2023
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
The researchers identified a set of biomarkers that may help distinguish whether pancreatic cysts are likely to develop into cancer or remain benign.
March 17, 2023
Blood test identifies acute myeloid leukemia patients at greater risk of relapse
According to a study, patients in remission from acute myeloid leukemia who have residual detectable mutations have higher relapse rates after bone marrow transplants.
March 8, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Racial groups negatively impacted by exclusion from cancer research
Researchers are calling for greater inclusion of people with African ancestry in genomic research to improve prostate cancer outcome disparities.
March 10, 2023
Spectrum Healthcare Partners adopts Proscia digital pathology platform
The addition of Proscia's Concentriq Dx digital platform will allow Spectrum Healthcare Partners to expand the reach of its experts across the healthcare systems it serves in Maine and New Hampshire.
March 13, 2023
At USCAP 2023, ProPhase Labs to present data about esophageal cancer screening test
The upcoming presentation in New Orleans is scheduled for March 14 and entitled "Targeted Mass Spectrometry of Barrett's Esophagus Reveals High-Fidelity Combinatorial Molecular Correlates."
March 13, 2023
PathAI announces adoption of digital pathology products by anatomic pathology laboratories
A network of laboratories will be the first to access PathAI's growing menu of algorithm products for oncology and non-oncology indications.
March 9, 2023
Mindpeak AI algorithms for IHC available on Paige pathology platform
The firms combined their technologies to help pathologists deliver fast, accurate, and reproducible quantitative cancer diagnoses, even in the most challenging and complex cases, Paige said.
March 9, 2023
Alverno Laboratories to expand Ibex’s AI-powered cancer diagnostics suite throughout its Midwest network
Alverno, among the first U.S. laboratory networks to digitize its pathology services, is also the first to offer the Ibex AI-supported cancer diagnostic service in the U.S.
March 9, 2023
Page 1 of 81
Next Page
